Case Studies 5

A leading company in the biotechnology marketplace had a novel, but underperforming, asset in dermatology. Easton Associates’ engagement had the short-term objective of developing a life-cycle strategy for the product that enhanced its value to the corporation and then looked at the broader opportunities to build a true therapeutic franchise. In the second part of our analysis, EA led the due diligence efforts to assess specific licensing and acquisition targets, culminating in a comprehensive market model in support of the new strategy.